Tech Company Financing Transactions
Semma Therapeutics Funding Round
Semma Therapeutics, based in Cambridge, secured investment capital from JDRF T1D Fund.
Transaction Overview
Company Name
Announced On
3/23/2017
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
This investment from the JDRF T1D Fund will provide Semma with critical resources to move us closer to taking a product candidate into the clinic, and represents a validation of our work by JDRF, a leader in T1D research.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
450 Kendall St. 2B
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Not Recorded
Overview
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bastiano Sanna
Chief Financial Officer
David Cordo
Chief Marketing Officer
Moses Goddard
Chief Technical Officer
David DiGiusto
Founder
Doug Melton
Vice President
Jason Gaglia
Vice President
Christopher Thanos
VP - Operations
Jeffrey Imbaro
VP - R & D
Felicia Pagliuca
Browse more venture capital transactions:
Prev: 3/23/2017: Wrightspeed venture capital transaction
Next: 3/23/2017: Casetext venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs